Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MT921 in Moderate to Severe Submental Fat
NCT04144049Phase 2Completed
- Sponsor
- Medytox Inc.
- Start
- Sep 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Nuviju in submental fat, sponsored by Medytox Inc.. Started Sep 2019; status: completed.
02
Drugs
Nuviju
03
Conditions
submental fat
Beyond the preview
Go deeper on NCT04144049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04144049.